Showing results (21-30 of 31) with videos related to
Sort By:
Pageof 4
Proceedings of the National Academy of Sciences of the United States of America|March 29, 2017
Mouse-adapted MERS coronavirus causes lethal lung disease in human DPP4 knockin miceKun Li, Christine L Wohlford-Lenane, Rudragouda Channappanavar, et al.Frontiers in Immunology|December 7, 2020
Tumor-Specific Antibody, Cetuximab, Enhances the <i>In Situ</i> Vaccine Effect of Radiation in Immunologically Cold Head and Neck Squamous Cell CarcinomaWon Jong Jin, Amy K Erbe, Ciara N Schwarz, et al.Journal for Immunotherapy of Cancer|January 13, 2023
Radiation to all macroscopic sites of tumor permits greater systemic antitumor response to in situ vaccinationPeter M Carlson, Ravi B Patel, Jen Birstler, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 15, 2024
Functionality of bone marrow mesenchymal stromal cells derived from head and neck cancer patients - A FDA-IND enabling study regarding MSC-based treatments for radiation-induced xerostomiaGrace C Blitzer, Cristina Paz, Annemarie Glassey, et al.Science Translational Medicine|July 15, 2021
Low-dose targeted radionuclide therapy renders immunologically cold tumors responsive to immune checkpoint blockadeRavi B Patel, Reinier Hernandez, Peter Carlson, et al.Journal for Immunotherapy of Cancer|July 22, 2020
In situ vaccination at a peripheral tumor site augments response against melanoma brain metastasesPaul A Clark, Raghava N Sriramaneni, Won Jong Jin, et al.Radiation Research|April 7, 2021
Low-Dose Radiation Potentiates the Propagation of Anti-Tumor Immunity against Melanoma Tumor in the Brain after In Situ Vaccination at a Tumor outside the BrainPaul A Clark, Raghava N Sriramaneni, Amber M Bates, et al.Frontiers in Immunology|December 6, 2021
Radiation Augments the Local Anti-Tumor Effect of <i>In Situ</i> Vaccine With CpG-Oligodeoxynucleotides and Anti-OX40 in Immunologically Cold Tumor ModelsAlexander A Pieper, Luke M Zangl, Dan V Speigelman, et al.Theranostics|May 17, 2021
Temporal analysis of type 1 interferon activation in tumor cells following external beam radiotherapy or targeted radionuclide therapyJustin C Jagodinsky, Won Jong Jin, Amber M Bates, et al.Biorxiv : the Preprint Server for Biology|July 29, 2024
Effects of clinically relevant radionuclides on the activation of a type I interferon response by radiopharmaceuticals in syngeneic murine tumor modelsCaroline P Kerr, Julia Sheehan-Klenk, Joseph J Grudzinski, et al.Pageof 4